Abstract
A decade has now elapsed since liposomes were first proposed1–3 as vehicles for drug delivery in biology and medicine. During this time extensive studies have revealed a multitude of uses4 and at the same time established many of the principles governing the system’s behaviour within the biological milieu.5–7 Among the advantages that liposomes offer as a drug carrier system, versatility in structural characteristics is most prominent. For instance, appropriate choice of lipid composition, size, surface charge and also of surface ligands that can recognise and associate with, target cells selectively can all profoundly influence the fate and behaviour of the carrier and thus contribute towards optimising the action of its drug contents. One of the major objectives in the use of liposomes in vivo is interaction with accessible cells i.e. those in the blood circulation, lining the capillaries and, in certain cases, cells in extravascular areas separated from the circulation by leaky membranes. There is, therefore, a need for drugs to be retained by the carrier for periods of time necessary for effective access to, and association with the target. Here we have attempted to understand factors that influence (a) quantitative retention of drugs by liposomes in vitro and in vivo (b) rates of liposome clearance from the circulation and (c) targeting of liposomes to specific cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
G. Gregoriadis and B.E. Ryman, Liposomes as carriers of enzymes or drugs: A new approach to the treatment of storage diseases, Biochem. J. 124: 58P (1971).
G. Gregoriadis and B.E. Ryman, Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases, Eur. J. Biochem. 24: 485 (1972).
G. Gregoriadis and B.E. Ryman, Lysosomal localization of enzyme-containing liposomes injected into rats, Biochem. J. 128: 142 (1972).
G. Gregoriadis, Targeting of Drugs: Implications in Medicine, Lancet, 2: 241 (1981).
G. Gregoriadis, The carrier potential of liposomes in Biology and Medicine, New Engl. J. Med. 295: 704 (1976).
G. Gregoriadis, The carrier potential of liposomes in Biology and Medicine, New Engl. J. Med. 295: 765 (1976).
B.E. Ryman and D.A. Tyrrell, Bags of potential, Essays Biochem. 16: 49 (1980).
G. Gregoriadis, Drug entrapment in liposomes, FEBS Lett., 36: 292 (1973).
L. Krupp, A.V. Chobanian and I.P. Brecher, The in-vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat, Biochem. Biophys. Res. Comm. 72: 1251 (1976).
G. Scherphof, F. Roerdink, M. Waite and J. Parks, Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high density lipoproteins, Biochim. Biophys. Acta. 542: 296 (1978).
T.M. Allen, A study of phospholipid interaction between high density lipoproteins and small unilamellar vesicles, Biochim. Biophys. Acta. 640: 385 (1981).
C. Kirby, J. Clarke and G. Gregoriadis, Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum, FEBS Lett. 111: 324 (1980).
C. Kirby and G. Gregoriadis, The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vivo, Life Sciences, 27: 2223 (1980).
L.S.S. Guo, R.L. Hamilton, J. Goerke, J.N. Weinstein and R.J. Havel, Interaction of unilamellar liposomes with serum lipoproteins and apolipoprotein, J. Lipid Res. 21: 993 (1980).
P.D. Ladbrooke, R.M. Williams and D. Chapman, Studies on lecithin-cholesterol-water interactions by differential scanning calorimetry and X-ray diffraction, Biochim. Biophys. Acta, 150: 333 (1968).
R.A. Demel and B. Kruyff, The function of sterols in membranes, Biochim. Biophys. Acta. 457: 109 (1976).
D. Papahadjopoulos, K. Jacobson, S. Nir and T. Isac, Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol, Biochim. Biophys. Acta., 311: 330 (1973).
G. Gregoriadis and C. Davis, Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells, Biochem. Biophys. Res. Comm. 89: 1287 (1979).
C. Kirby, J. Clarke and G. Gregoriadis, Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro, Biochem. J. 186: 591 (1980).
G. Gregoriadis and J. Senior, The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation, FEBS Lett. 119: 43 (1980).
J. Senior and G. Gregoriadis, Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components, (Submitted).
A.R. Tall, Studies on the transfer of phosphatidylcholine from unilamellar vesicles into plasma high density lipoproteins in the rat, J. Lipid Res., 21: 354 (1980).
G. Scherphof, J. Damen, D. Hoekstra, A.J.B.M. Van Renswoode and F.H. Roerdink, Fundamental studies on the cellular uptake of liposomes, in: “Cell Biological Aspects of Disease”, Th. W. Daems, E.H. Burger and B.A. Afzelius, eds., Leiden University Press, The Hague (1980).
C. Kirby and G. Gregoriadis, Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers. Biochem. J., 199: 251 (1981).
C. Kirby and G. Gregoriadis, The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection (Submitted).
D.S. Alberts, S.Y. Chang, H-S.G. Chen, T.E. Moon, T.L. Evans, R.L. Furner, K. Himmelstein and J.F. Gross, Kinetics of intravenous melphalan, Clin. Pharmacol. Ther., 26: 73 (1979).
R.L. Juliano and D. Stamp, Interactions of drugs with lipid membranes: Characteristics of liposomes containing polar or non-polar antitumour drugs, Biochim. Biophys. Acta., 586: 137 (1979).
K.J. Huang, K-F.S. Luke and P.L. Beaumier, Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study, Proc. Nat. Acad. Sci. USA, 77: 4030 (1980).
C.D.V. Black and G. Gregoriadis, Interaction of liposomes with blood plasma proteins, Biochem. Soc. Trans., 4: 253 (1976).
D.A. Tyrrell, V.J. Richardson and B.E. Ryman, The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver, Biochim. Biophys. Acta., 497: 469 (1977).
G. Gregoriadis, D.E. Neerunjun and R. Hunt, Fate of a liposome-associated agent injected into normal and tumour bearing rodents. Attempts to improve localization in tumour tissues, Life Sciences, 21: 357 (1977).
P. Large and G. Gregoriadis, The effect of storage on the stability of drug-containing small unilamellar liposomes (Submitted).
G. Gregoriadis and E.D. Neerunjun, Homing of liposomes to target cells, Biochem. Biophys. Res. Comm., 65: 537 (1975).
V.P. Torchilin, V.G. Omel Yanenko, A.L. Klibanov, A.I. Michailov, V.I. Gol’Danskii and V.N. Smirhov, Incorporation of hydrophilic protein modified with hydrophobic agent into liposome membrane, Biochim. Biophys. Acta., 602: 511 (1980).
P. Ghosh, P.K. Das and B.K. Bachhawat, Selective uptake of liposomes by different cell types of liver through the involvement of liposomal surface glycosides, Biochem. Soc. Trans., 9: 512 (1981).
A. Huang, L. Huang and S.J. Kennel, Monoclonal antibody covalently coupled with fatty acid, J. Biol. Chem. 255: 8015 (1980).
L.D. Leseruran, J. Barbet, F. Kourilsky and J.N. Weinstein, Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A, Nature, 288: 602 (1980).
T.D. Heath, R.T. Fraley and D. Papahadjopoulos, Antibody targeting of liposomes: cell specificity obtained by conjugation of F(ab’)2 to vesicle surface, Science, 210: 539 (1980).
V.K. Jansons and P.L. Mallett, Targeted liposomes: a method for preparation and analysis, Anal. Biochem. 111: 54 (1981).
G. Gregoriadis, A. Meehan and M.M. Mah, Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo: Some influencing factors, Biochem. J. 200: 203 (1981).
G. Gregoriadis and A. Meehan, Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells: the effect of antibody and antigen concentration on the liposomal and cell surface respectively, Biochem. J. 200: 211 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Gregoriadis, G., Kirby, C., Large, P., Meehan, A., Senior, J. (1982). Targeting of Liposomes: Study of Influencing Factors. In: Gregoriadis, G., Senior, J., Trouet, A. (eds) Targeting of Drugs. NATO Advanced Study Institutes Series, vol 47. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4241-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4241-0_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4243-4
Online ISBN: 978-1-4684-4241-0
eBook Packages: Springer Book Archive